
CAS than after CEA for symptomatic patients (1.0% 6
0.4% vs 2.3% 6 0.6%; HR, 0.45; 95% CI, 0.18-1.11; P < .08);
however, the differences were not signiﬁcant. The CSTC
(Carotid Stenosis Trialists’ Collaboration) performed a
meta-analysis of 